MEDIGROUP
ActiveSummary
MEDIGROUP has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €23.7m and a net result of -€201,774. Equity is growing by about 15% per year across the filed financial years. Its solvency ranks better than 84% of 6,136 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Group and network
Holdings and subsidiaries
5 holdings · 6 subsidiaries in the treeHoldings 5
Source for every holding own accounts 2025
- Beta Active PI Pharma LtdIEsubsidiaryEquity €4.5mResult -€972,660100%
- ECO.PHARMA.SUPPLYsubsidiaryEquity €159,479Result -€337,585100%
- ECOPHARMASUPPLY DISTRIBUTIONsubsidiaryEquity €403,348Result €8,747100%
- IMPEXECOsubsidiaryEquity €2.4mResult €139,788100%
- PI PHARMAsubsidiaryEquity -€161,750Result €174,639100%
All subsidiaries, including indirect ones 6
Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.
- Beta Active PI Pharma LtdIE 100%
ECO.PHARMA.SUPPLY 100%1 subsidiary
- ECO.PHARMA.SUPPLY B.V.NL 100%
- ECOPHARMASUPPLY DISTRIBUTION 100%
- IMPEXECO 100%
- PI PHARMA 100%
According to the 2025 annual accounts of MEDIGROUP and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
2 connected companiesThe connected companies are in the list below.